BioSpeedia is a biotechnology company founded by two scientific researchers from Institut Pasteur and is part of an outstanding scientific ecosystem.
- Founded in 2011
The establishment of BioSpeedia
After spending 3 decades at Institut Pasteur, Yves Germani and Evelyne Begaud, establish the Company as the official spin-off from the premier French Institute.
Grant from AIMA Lab
Grant from OSEO Crea Dev / BPI
Grant from Aide au Partenariat Technologique
Developed fast and accurate lateral flow diagnostic kit to detect Neisseria meningitidis (Menincococcus)
Developed a diagnostic kit to rapidly detect bacterial meningitis using spinal fluid and subsequently using urine samples.
WHO approves MeningoSpeed detection kit in spinal fluid
Received CE Mark for its SARS-Cov-2 rapid antibody test kit
COVID19SEROSpeed-IgM-IgG Test is an immunochromatographic assay designed for the qualitative detection and differentiation of specific IgM and IgG antibodies to coronavirus 2019-nCoV or SARS-CoV-2 in human fingertip blood samples
Seal of Excellence from H2020
For COVID-19 Response